Skip to main content
Fig. 8 | Microbial Cell Factories

Fig. 8

From: Expression of a recombinant FLT3 ligand and its emtansine conjugate as a therapeutic candidate against acute myeloid leukemia cells with FLT3 expression

Fig. 8

Analysis of FL-DM1 on primary AML cells. a Typical FLT3-negative primary AML cells treated with FL-DM1 (10 nM). b Typical FLT3-positive primary AML cells treated with FL-DM1 (10 nM). c Statical analysis of Annexin V positive population increment in two groups (FLT3-negative group and FLT3-positive group) after FL-DM1 (10 nM) treatment, **: p < 0.01

Back to article page

Microbial Cell Factories

ISSN: 1475-2859

Contact us